| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 8790068 | Urologic Oncology: Seminars and Original Investigations | 2018 | 8 Pages | 
Abstract
												PSR is a novel prognostic factor in patients with aUC receiving first-line platinum-based chemotherapy.
											Related Topics
												
													Health Sciences
													Medicine and Dentistry
													Oncology
												
											Authors
												Hiroshi M.D., Madoka M.D., Yasukazu M.D., Ph.D., Kazumasa M.D., Kosuke M.D., Ph.D., Hiroaki M.D., Masaya M.D., Ph.D., Ken-ichi M.D., Ph.D., Yasuhisa M.D., Ph.D., Fumitaka M.D., Ph.D., 
											